22 results
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
12 Feb 24
Regulation FD Disclosure
4:15pm
activities of those cells that support specific disease-modifying mechanisms, such as immunomodulation, anti-inflammation, and regeneration. Celularity’s … amniotic membrane derived from the placenta of a healthy, full-term pregnancy that provides a foundation for the wound regeneration process and acts
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
31 May 23
THE NEXT EVOLUTION IN CELLULAR MEDICINE Investor Presentation June 2023
5:08pm
Biovance®: Intact, natural extracellular matrix that provides a foundation for the wound regeneration process and acts as a scaffold for restoration
S-4
EX-10.18
CELU
Celularity Inc - Ordinary Shares
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
is employed by the Company as its President, Functional Regeneration pursuant to an employment offer with the Company dated August 30, 2019 (the “Prior … shall continue to serve as President, Functional Regeneration. During the term of Executive’s employment with the Company, and excluding periods
424B3
CELU
Celularity Inc - Ordinary Shares
2 Jun 23
Prospectus supplement
5:00pm
extracellular matrix that provides a foundation for the wound regeneration process and acts as a scaffold for restoration of functional tissue. Interfyl is human
424B5
k9y3mi7q0 xei
6 Apr 23
Prospectus supplement for primary offering
9:03pm
424B5
vufuk65oqshheqmsllrd
28 Jul 23
Prospectus supplement for primary offering
4:24pm
424B3
uku45uabxfi4g5 hzw
1 Jun 22
Prospectus supplement
4:06pm
424B3
yg9dvcu620u41
3 May 22
Prospectus supplement
4:06pm
POS AM
hrra0fqk wv6q76rkz
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
7omhu92u
12 Aug 21
Prospectus supplement
4:21pm